Lakeway, NY -- (SBWIRE) -- 02/06/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
ADTRAN, Inc. (NASDAQ:ADTN) shares jumped 3.75% and closed at $20.49 in the last trading session. The company, on Feb. 1, will begin trading ex-dividend on February 05, 2013. A cash dividend payment of $0.09 per share is scheduled to be paid on February 21, 2013. Shareholders who purchased ADTN stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 31st quarter that ADTN has paid the same dividend.
What Should Be The Fair Value Of ADTN After today’s Gain? Let’s Find Out Here
Banco Santander, S.A. (ADR) (NYSE:SAN) stock gained 3.26% to $7.92. The company, on Jan. 21, has priced EUR 2 billion bonds with coupon of 2.875%, 195 basis points over mid-swaps and maturity date on January 30, 2018. Barclays, Bank of America Merrill Lynch, CA CIB, Natixis and Santander are lead managers on the deal.
Will SAN A Buy Following poor Earnings? Find Out Here
Thermo Fisher Scientific Inc. (NYSE:TMO) shares jumped 3.24% to $74.79 after the company yesterday announced that The Manufacturing Institute, Deloitte, University of Phoenix and the Society of Manufacturing Engineers recently recognized Lisa Witte, VP/GM of its Portable Analytical Instruments business, with a Women in Manufacturing STEP (Science, Technology, Engineering and Production) Award.
Additionally, the company, on Jan. 31, posted fourth quarter net income of $376.4 million or $1.04 per share from $288.9 million or $0.77 per share in the same period last year. Income from continuing operations totaled $385.8 million or $1.07 per share. Adjusted earnings for the quarter were $1.36 per share. Analysts expected the company to earn $1.28 per share for the quarter. Revenues increased 6% to $3.26 billion from $3.09 billion last year. Analysts expected revenues of $3.14 billion.
What Should Be The Fair Value Of TMO After today’s Gain? Let’s Find Out Here
Cannabis Science Inc. (PINK:CBIS) slipped 9.57% and closed at $0.0850 on a traded volume of 70.91 million shares. The Company announced its Corporate Operational Guidance for 2013. The guidance highlights a strategic action plan to bring to market innovative, cannabinoid-based, life-saving, anti-cancer drugs. The Company anticipates releasing a variety of cannabinoid-based treatments that already show great promise in fighting HIV-related illnesses like Kaposi's Sarcoma that is on the rise due to the developing resistance to all current classes of anti-retroviral drugs.
Is CBIS A Buy After Today’s Gain? Get Free Trend Analysis Here
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at www.ThePennyStockProfiler.com
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)